From Fen-Phen to Lap Bands: Six Weight Loss Treatments Medicine Left Behind

The history of obesity treatment is littered with interventions that once promised revolutionary results but ultimately fell from favor due to safety concerns, poor outcomes, or the arrival of more effective alternatives. Understanding why these treatments failed offers a sobering lesson in the gap between medical hope and medical reality.

Fen-phen, a combination of fenfluramine and phentermine, was among the most widely prescribed weight loss drugs of the 1990s. Millions of Americans took the drug pairing before studies linked it to serious heart valve damage and a rare but deadly lung condition called primary pulmonary hypertension. The FDA requested its withdrawal in 1997, and the fallout resulted in billions of dollars in lawsuits against manufacturer Wyeth.

Gastric banding, often referred to by the brand name Lap-Band, was once considered a less invasive alternative to gastric bypass surgery. The adjustable silicone band placed around the upper stomach fell out of favor as long-term data showed high rates of complications, including band slippage, erosion, and the need for reoperation. Many bariatric surgeons now rarely perform the procedure.

Ephedra-based supplements dominated the diet industry through the late 1990s and early 2000s, marketed aggressively as thermogenic fat burners. The stimulant, derived from the ma huang plant, was linked to heart attacks, strokes, and at least 155 deaths before the FDA banned its sale in dietary supplements in 2004, marking one of the agency's most significant supplement enforcement actions.

Jaw wiring, a procedure that physically restricted patients from eating solid food, was practiced in the 1970s and 1980s as a drastic measure for severe obesity. While patients did lose weight during the wiring period, the approach was psychologically distressing, carried risks of aspiration in emergencies, and produced virtually no lasting results once the wires were removed.

Intestinal bypass surgery, a precursor to modern bariatric procedures, involved bypassing a large portion of the small intestine to reduce nutrient absorption. While effective for weight loss, the surgery caused severe nutritional deficiencies, liver failure in some patients, and debilitating diarrhea. It was largely abandoned by the 1980s in favor of safer surgical techniques.

The pattern across these discarded treatments is consistent: initial enthusiasm driven by short-term results, followed by the emergence of serious long-term harms. Medical experts say the cycle underscores the importance of rigorous long-term clinical trials before widespread adoption. As newer options like GLP-1 receptor agonists reshape obesity medicine today, researchers warn against repeating the mistakes of the past.